| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,184 |
2,418 |
$110K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
1,352 |
1,290 |
$53K |
| 99152 |
|
855 |
759 |
$6K |
| 90961 |
|
191 |
189 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
37 |
36 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
84 |
79 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
131 |
114 |
$2K |
| 36902 |
|
27 |
27 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
15 |
12 |
$97.84 |
| 90970 |
|
23 |
12 |
$45.99 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
766 |
707 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
462 |
429 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
17 |
12 |
$0.00 |
| 6030F |
|
14 |
14 |
$0.00 |
| 1123F |
|
175 |
164 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
146 |
138 |
$0.00 |